2026 NPPES data Allergy & Immunology Physician NPI 1104056027 MD
Verify on CMS →

MATTHEW FELDMAN, MD

Allergy & Immunology Physician in DALLAS, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
266
Medicare Part D claims · 59 beneficiaries · Allergy & Immunology Physician avg: 764
Generic prescribing
56%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$38.5K
103 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MATTHEW FELDMAN, MD is a Allergy & Immunology Physician ([object Object]) practicing in DALLAS, Texas with a Medicare Part D prescribing footprint of 266 claims across 59 beneficiaries — 44% brand-name prescribing . Industry payments of $38.5K across 103 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MATTHEW FELDMAN, MD filed 266 Medicare Part D claims in 2023 across DALLAS, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

MATTHEW FELDMAN, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

MATTHEW FELDMAN, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 07/27/2009

NPI 1104056027

Primary specialty

Allergy & Immunology Physician

Niche

3,390 US NPIs in this specialty

Medicare Part D claims

266 65% vs specialty avg

2023 prescription claims

Specialty avg: 764

Specialty distribution in Texas

How Allergy & Immunology Physician compares to other specialties among Texas providers

Texas providers

Allergy & Immunology Physician share within Texas

1. Allergy & Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy & Immunology Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Allergy & Immunology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Allergy & Immunology Physician ABMS/AOA estimate

Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATTHEW FELDMAN, MD is a Allergy & Immunology Physician provider practicing in DALLAS, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1104056027. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MATTHEW FELDMAN, MD appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding MD credentials at 7557 RAMBLER RD STE 400, DALLAS, TX, 75231, with a listed phone of (214) 347-7337. NPI 1104056027 was issued on 07/27/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FELDMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 266 prescription claims written by this provider, covering 59 Medicare beneficiaries and totaling roughly $150K in drug spend, split 44% brand-name and 56% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7557 RAMBLER RD STE 400
DALLAS, TX 75231

Provider Details

NPI 1104056027
Specialty Allergy & Immunology Physician
Credentials MD
Gender Male
NPI Issued 07/27/2009

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW FELDMAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$38.5K

Largest payer

Regeneron Healthcare Solutions, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MATTHEW FELDMAN, MD. To verify MATTHEW FELDMAN, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MATTHEW FELDMAN, MD — brand share 44.0%
Specialty average (est.)

44% brand-name claims vs 56% generic, on 266 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

266
Total Claims
$150K
Total Drug Cost
59
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
363
Total Day Supply
9,506
Brand vs Generic
44% brand / 56% generic
Brand Drug Cost
$145K
Generic Drug Cost
$5K
Antibiotic Claims
20

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
0.82
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Dupixent Syringe
Dupilumab
27
Pantoprazole Sodium
23
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
22
Albuterol Sulfate Hfa
Albuterol Sulfate
21
Ipratropium Bromide
18
Montelukast Sodium
17
Symbicort
Budesonide/Formoterol Fumarate
17
Prednisone
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy & Immunology Physician Overview

How MATTHEW FELDMAN, MD fits within the Allergy & Immunology Physician landscape nationally.

3,390
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
764
Avg Claims per Provider

MATTHEW FELDMAN, MD's 266 claims are below the specialty average of 764.

Nearby Allergy & Immunology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as FELDMAN.

Compare Allergy & Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATTHEW FELDMAN, MD's specialty?
MATTHEW FELDMAN, MD specializes in Allergy & Immunology Physician and practices in DALLAS, Texas. Credentials: MD.
How much does MATTHEW FELDMAN, MD prescribe under Medicare Part D?
In 2023, MATTHEW FELDMAN, MD wrote 266 Medicare Part D claims totaling $150K in drug costs for 59 beneficiaries.
Where is MATTHEW FELDMAN, MD located?
MATTHEW FELDMAN, MD is located at 7557 RAMBLER RD STE 400, DALLAS, TX, 75231. Phone: (214) 347-7337.
What is MATTHEW FELDMAN, MD's NPI number?
MATTHEW FELDMAN, MD's National Provider Identifier (NPI) is 1104056027, issued on 07/27/2009.
Does MATTHEW FELDMAN, MD prescribe more brand-name or generic drugs?
MATTHEW FELDMAN, MD's prescribing is 44% brand-name and 56% generic drugs by claim count, with $145K in brand drug costs.
How many Allergy & Immunology Physician providers are there in the US?
There are 3,390 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 764 Medicare Part D claims per year.
What drugs does MATTHEW FELDMAN, MD prescribe most often?
Based on 2023 Medicare Part D data, MATTHEW FELDMAN, MD's most frequently prescribed drugs include Dupixent Syringe, Pantoprazole Sodium, Trelegy Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATTHEW FELDMAN, MD accept Medicare?
MATTHEW FELDMAN, MD appears in CMS Medicare data with 266 Part D claims and 59 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATTHEW FELDMAN, MD's credentials?
MATTHEW FELDMAN, MD's NPI is 1104056027 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology